Clinical Trials Logo

Thyroid Cancer clinical trials

View clinical trials related to Thyroid Cancer.

Filter by:

NCT ID: NCT04463719 Recruiting - Thyroid Cancer Clinical Trials

AIM2: Adequate Selection of Patients for Thyroid Biopsy: Evaluation of a Shared Decision Making Conversation Aid

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

There is an epidemic of thyroid cancer that is harmful to patients and the medical system. The study hypothesizes that the use of an electronic conversation aid during clinical visits can help patients and clinicians collaborate. The study aims to update a conversation aid prototype that was developed to support shared decision making in the diagnosis of thyroid cancer and conduct a pilot clinical trial to evaluate the feasibility of conducting a larger efficacy study.

NCT ID: NCT04424485 Recruiting - Thyroid Cancer Clinical Trials

Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy

Start date: June 1, 2020
Phase: N/A
Study type: Interventional

Indocyanine green (ICG) is a water-soluble organic dye that is cleared totally through the hepatobiliary system. It has a half-life of 3-4 mins, which allows repeated applications. Near-infrared (NIR) fluorescence imaging with indocyanine green (ICG) imaging has been recently introduced, and has been suggested as a useful tool for the identification and preservation of the parathyroid glands (PGs) during total thyroidectomy (TT). ICG can also be used for sentinel lymph node (SLN) biopsy to predict the micrometastases in central lymph nodes (CLN) in thyroid carcinoma, and central lymph node dissection can reduce local recurrence.

NCT ID: NCT04410601 Recruiting - Thyroid Cancer Clinical Trials

Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT

Dysphagia-TT
Start date: May 14, 2020
Phase: N/A
Study type: Interventional

The most common and feared complications of total thyroidectomy are vocal cord paralyses and hypocalcemia. However, post-thyroidectomy dysphagia is not uncommon and has important consequences on the quality of life (QoL). It should be taken seriously by all clinicians.

NCT ID: NCT04396912 Recruiting - Thyroid Cancer Clinical Trials

Post-thyroidectomy Vocal Cord Paralysis Along With Hypocalcemia: STROBE - Guided Prospective Cohort

Start date: May 15, 2020
Phase:
Study type: Observational

In the present study, the severity of recurrent laryngeal nerve injury (RLNI) and hypocalcemia (H) will be followed-up and the probable interrelation between them will be proposed considering the clinical situation of patients, e.g. improvement in hypocalcemia also make a positive effect on voice? (any objective sign? Ca? PTH?), return of voice is parallel with the improvement in hypocalcemia? Postoperative calcium (Ca), parathyroid hormone (PTH), regular vocal cord evaluations by ear-nose-throat (ENT) exams, deterioration-stability-improvement of clinical symptoms regarding both Ca metabolism and vocal cord function will be noted at regular intervals (postoperative day 1-3-first, weekly control/first month, monthly/first 6-month, 3-monthly/6-12 months) at outpatient controls. Serum Ca, PTH, ENT evaluation of vocal cords-noted.

NCT ID: NCT04339478 Recruiting - Thyroid Cancer Clinical Trials

Does Parathyroid Autofluorescence Reduces Unintensional Parathyroidectomy During Total Thyroidectomy With Central Lymph Node Compartment Dissection

FLUOBCC
Start date: April 6, 2020
Phase:
Study type: Observational

The aim of the study is to evaluate the effectiveness of autofluorescence in the intraoperative preservation of parathyroids during total thyroidectomy with central lymph node compartment dissection.

NCT ID: NCT04320901 Recruiting - Thyroid Cancer Clinical Trials

Energy Device Study in Transoral Endoscopic Thyroidectomy

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Open label randomized controlled study, for Harmonic versus Ligasure in transoral endoscopic thyroid surgery.

NCT ID: NCT04312087 Recruiting - Thyroid Cancer Clinical Trials

Lateral Neck Lymph Node Mapping in Thyroid Cancer

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

This study includes papillary thyroid cancer patients who have unpalpable lateral neck lymph nodes but suspicious on ultrasound and/or CT. Carbon nanoparticles is used as the tracer for lateral neck lymph node mapping.

NCT ID: NCT04290663 Recruiting - Thyroid Cancer Clinical Trials

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

INTERMEDIATE
Start date: March 2, 2020
Phase: Phase 3
Study type: Interventional

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

NCT ID: NCT04285476 Recruiting - Thyroid Cancer Clinical Trials

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

PREDICYTHY
Start date: June 17, 2021
Phase: N/A
Study type: Interventional

The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.

NCT ID: NCT04248166 Recruiting - Thyroid Cancer Clinical Trials

Thyroid Cancer and Photoacoustic Imaging

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the usefulness of photoacoustic imaging in thyroid nodules. In addition, we would like to confirm the relationship between the results of photoacoustic imaging and histopathologic findings when thyroid nodules were diagnosed as thyroid cancer.